MyFinsight
Home
About
Contact
pcvx: the balance sheet
Income Statement
|
Cash Flow
|
Balance Sheet
For the quarter ending 2025-09-30, PCVX has $3,171,600K in assets.
Balance Sheets Overview
00
No enough data to generate the overview
Buy me a coffee
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Quarterly
123
Balance Sheets
2025-09-30
2025-06-30
Total assets
3,171,600
3,305,363
Total stockholders' equity
2,892,882
3,071,334
Total liabilities and stockholders' equity
3,171,600
3,305,363
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Page 1
Subscribe for Financial Insights
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Other assets
$106,708K
Restricted cash
$1,468K
Long-term investments
$959,256K
Operating lease
right-of-use assets
$83,515K
Property and equipment,
net
$253,486K
Prepaid expenses and
other current assets
$55,847K
Short-term investments
$1,430,240K
Cash and cash
equivalents
$281,080K
Total noncurrent
assets
$1,404,433K
Total current assets
$1,767,167K
Total assets
$3,171,600K
Total liabilities and
stockholders' equity
$3,171,600K
Total stockholders'
equity
$2,892,882K
Total liabilities
$278,718K
Accumulated deficit
-$1,908,440K
Accumulated other
comprehensive loss
$856K
Additional paid-in capital
$4,800,333K
Operating lease
liabilities long-term
$78,672K
Total current
liabilities
$200,046K
Common stock, 0.001 par
value 500,000,000...
$133K
Operating lease
liabilities current
$5,771K
Accrued expenses
$24,592K
Accrued contract
manufacturing expenses
$103,959K
Accrued compensation
$16,762K
Accounts payable
$48,962K
Buy me a coffee
Vaxcyte, Inc. (PCVX)
Vaxcyte, Inc. (PCVX)